RA Capital Management - NEWAMSTERDAM PHARMA COMPANY ownership

NEWAMSTERDAM PHARMA COMPANY's ticker is and the CUSIP is N62509117. A total of 24 filers reported holding NEWAMSTERDAM PHARMA COMPANY in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RA Capital Management ownership history of NEWAMSTERDAM PHARMA COMPANY
ValueSharesWeighting
Q3 2023$633,333
-9.1%
333,3330.0%0.01%
-7.7%
Q2 2023$696,666
+13.6%
333,3330.0%0.01%
-7.1%
Q1 2023$613,333
+111.9%
333,3330.0%0.01%
+133.3%
Q4 2022$289,433333,3330.01%
Other shareholders
NEWAMSTERDAM PHARMA COMPANY shareholders Q4 2022
NameSharesValueWeighting ↓
CAXTON CORP 21,333$40,5330.10%
Frazier Life Sciences Management, L.P. 500,333$920,6130.07%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 733,327$1,3570.05%
Exos TFP Holdings LLC 93,932$172,8350.04%
EcoR1 Capital, LLC 66,665$883,9780.03%
Affinity Asset Advisors, LLC 37,000$68,4500.02%
Bain Capital Life Sciences Investors, LLC 100,000$1840.02%
RA Capital Management 333,333$613,3330.01%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 92,787$170,7280.00%
Westchester Capital Management, LLC 31,189$57,6990.00%
View complete list of NEWAMSTERDAM PHARMA COMPANY shareholders